TherapeuticsMD, Inc. (TXMD) › Net IncomeTherapeuticsMD, Inc. (TXMD) — Net IncomeAnnual figures by fiscal year, from SEC filings.2010: -$2.87M2011: -$12.91M2012: -$35.12M2013: -$28.42M2014: -$54.22M2015: -$85.08M2016: -$89.88M2017: -$76.93M2018: -$132.62M2019: -$176.15M2020: -$183.52M2021: -$172.41M2022: $112.00M2023: -$10.28M2024: -$2.18M2025: -$569.0K-$569.0K2010Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$569.0K+73.9%2024-$2.18M+78.8%2023-$10.28M-109.2%2022$112.00M+165.0%2021-$172.41M+6.1%2020-$183.52M-4.2%2019-$176.15M-32.8%2018-$132.62M-72.4%2017-$76.93M+14.4%2016-$89.88M-5.6%2015-$85.08M-56.9%2014-$54.22M-90.8%2013-$28.42M+19.1%2012-$35.12M-172.0%2011-$12.91M-350.3%2010-$2.87M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share